Observed Signal · Nov 16, 2026 · mna · Source: SEC API · Impact: 3.8/5

Digimarc Enters Cooperation Agreement with Ocho Investments, Overhauling Board of Directors

Executive Signal Summary

On November 15, 2026, Digimarc Corporation entered into a Cooperation Agreement with Ocho Investments LLC, the beneficial owner of 5.0 million shares of common stock. Under the agreement, Digimarc expanded its Board of Directors from eight to eleven members, appointing Andris Upitis, Kevin McConnell, and Amy O'Keefe. Concurrently, four incumbent directors—Katie Kool, Sheila Cheston, Sandeep Dadlani, and LaShonda Anderson-Williams—tendered resignations effective December 31, 2026, which will reduce the board size to a capped maximum of nine directors. Ocho agreed to customary standstill, voting, and non-disparagement provisions through at least December 31, 2027. Additionally, CEO Paul Carreiro agreed to modify his compensation arrangements to waive change-of-control benefits triggered by the board reconstitution while lowering performance vesting stock price hurdles.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

Material activist cooperation agreement resulting in a substantial reconstituted majority and strategic oversight shift on Digimarc's Board of Directors without a proxy contest.

MARKET SIGNALS

Track Digimarc Signals & Strategic Shifts

Polaris7 connects regulatory filings, primary sources, leadership changes, and M&A activity into structured intelligence. Set up your Polaris7 workspace to monitor relevant companies in your executive briefing.

  • Verified primary sources
  • Automated briefings
  • Instant watchlist setup

Key Takeaways & Evidence Grounding

  • Appointed three new directors designated by 5.0M-shareholder Ocho Investments: Andris Upitis, Kevin McConnell, and Amy O'Keefe.
  • Accepted resignations of four existing directors effective December 31, 2026, capping future board size at nine directors.
  • Ocho Investments agreed to standstill and voting support commitments through the earlier of December 31, 2027, or 30 days prior to the 2028 director nomination window.
  • Each new director receives 100% of retainers in stock plus initial restricted stock awards valued at approximately $200,000 vesting over three years.
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: SEC API•Published: Nov 16, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

Leadership & PeopleNov 16, 2026

Oscar Appoints Three Independent Directors to Board, Expanding Size to Eleven

On November 12, 2026, the Board of Directors of Oscar Health, Inc. appointed Tomer Cohen, Eric Larsen, and Rajat Taneja as independent directors, effective November 13, 2026. In connection with these appointments, the Board expanded its total size from eight to eleven members. Each director will serve until the 2027 annual meeting of stockholders. Additionally, Mr. Cohen joined the Talent and Compensation Committee, while Mr. Taneja joined the Audit Committee and Nominating and Corporate Governance Committee. The newly appointed directors bring significant expertise across technology, consumer product scaling, enterprise security, healthcare advisory, and AI. They will receive standard non-employee director compensation comprising a $70,000 annual cash retainer, committee retainers ranging from $5,000 to $10,000, and initial and annual RSU grants valued at $200,000 each.

Read assessment
financialsOct 15, 2026

8-K/A Financial Filing Analysis for PassFort Limited (2026-10-15)

Moody's Corporation filed a Form 8-K/A on October 15, 2026, disclosing key changes to its Board of Directors and committee leadership. Director Jorge Bermudez, who served on the Board since April 2011, retired effective October 12, 2026, without any disagreement with the company. In recognition of his service, the Board accelerated the vesting of his February 2026 restricted stock unit (RSU) award by removing forfeiture restrictions. Following Bermudez's departure, Director Lisa Sawicki was appointed Chairman of the Audit Committee effective immediately. Additionally, Keith Demmings, previously elected to the Board with an effective date of November 1, 2026, was appointed to both the Governance & Nominating Committee and the Audit Committee. The total size of the Board remains unchanged at ten members.

Read assessment
financialsSep 22, 2026

8-K Financial Filing Analysis for Houlihan Lokey (2026-09-22)

Houlihan Lokey reported several key governance and leadership actions following its annual stockholder meeting on September 16, 2026. Stockholders approved the Second Amended and Restated 2016 Incentive Award Plan, which sets the reserved share pool at 12 million shares, reinstates an annual evergreen replenishment at a reduced 1% rate (down from 6%), and eliminates the fixed plan expiration date. Additionally, the company announced the election of Thomas Reichert to the Board as an independent Class I director effective October 1, 2026, receiving a $120,000 initial restricted stock grant. In executive leadership changes, General Counsel Christopher M. Crain retired to transition into a Corporate Senior Advisor role, and Prabha Sipi Bhandari was appointed as Chief Legal Officer and Secretary.

Read assessment

WATCHLIST & BRIEFINGS

Receive future signals for Digimarc & competitors in your briefing

Stay ahead of material M&A deals, leadership changes, account wins, and product rollouts. Polaris7 connects primary filings, company newsrooms, and trade reporting directly into your executive briefing.

  • Regular primary-source checks
  • Structured Watchlist briefings
  • Preserves current context